Buscar resultados de ensayos clínicos
Gaucher Disease - 63 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE) Condición: Gaucher Disease Fecha: 2010-02-23 Intervenciones: Drug: Eliglustat tartrate Oral Capsule in 50 mg or 100 mg dosages |
Completed |
Nombre del estudio: Auto-antibodies Prevalence and CD1 Role in Gaucher Disease Condición: Gaucher Disease Fecha: 2016-01-05 Intervenciones: Genetic: genetic analyses |
Completed |
Nombre del estudio: A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease Condición: Gaucher Disease Fecha: 2011-08-22 Intervenciones: Drug: Taliglucerase alfa Taliglucerase infusion every two weeks for 21 months |
Completed |
Nombre del estudio: Oral Miglustat in Adult Patients With Stable Type 1 Gaucher Disease Condición: Type 1 Gaucher Disease Fecha: 2006-04-26 Intervenciones: Drug: miglustat miglustat oral capsules 100mg three times daily (TID) |
Recruiting |
Nombre del estudio: SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease Condición: Gaucher Disease Fecha: 2015-09-09 |
Recruiting |
Nombre del estudio: Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1) Condición: Gaucher Disease Type 1 Fecha: 2015-08-21 Intervenciones: Drug: N-acetylcysteine 1800mg NAC twice daily (3600mg/day) orally for approximately 90 days. |
Completed |
Nombre del estudio: Oral Miglustat in Adult Patients With Stable Type 1 Gaucher Disease Condición: Type 1 Gaucher Disease Fecha: 2006-04-26 Intervenciones: Drug: miglustat miglustat oral capsules 100mg three times daily (TID) |
Not yet recruiting |
Nombre del estudio: Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease Condición: Type 1 Gaucher Disease Fecha: 2016-09-23 Intervenciones: Drug: Elelyso 60 units/kg All patients receive Elelyso 60 units/kg. |
Completed |
Nombre del estudio: Comparison of BMD Measurement by DEXA to BeamMed Speed-of-Sound Measurement at Forearm in Patients With Gaucher Disease Condición: Gaucher Disease Type 1 Fecha: 2014-01-27 Intervenciones: Device: BeamMed Speed-of-Sound bone strength test at forearm BeamMed Speed-of-Sound bone strength test a |
Terminated |
Nombre del estudio: A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101 Condición: Type 1 Gaucher Disease Fecha: 2009-04-02 Intervenciones: Drug: AT2101 225mg (nine 25mg capsules total dose) to be taken by mouth every day for 9 days (Study Days |